You are here

GSK, Sanofi to make 200m doses available for Covid-19 vaccine alliance

nz_vaccine_281075.jpg
French drugmaker Sanofi and Britain's GlaxoSmithKline plan to make 200 million doses of their Covid-19 vaccine candidate available to the vaccine allocation plan co-led by Gavi and the World Health Organization.

[BENGALURU] French drugmaker Sanofi and Britain's GlaxoSmithKline plan to make 200 million doses of their Covid-19 vaccine candidate available to the vaccine allocation plan co-led by Gavi and the World Health Organization.

The companies said on Wednesday they have signed a statement of...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes